GlassScriptPhysician profile
Cambize Shahrdar
NPI 1841229978
$3,259.49
in general payments reported to CMS, 2019-2025
16 companies · $600 in 2025
The $600 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.00 · 2020: $149 · 2021: $1,582 · 2022: $83.26 · 2023: $328 · 2024: $428 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,147.62 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $876.97 | 2019-2025 | |
| Sanara Medtech INC. | $398.57 | 2024-2025 | Celleraterx, Biasurge |
| Davol INC. | $202.68 | 2025 | Arista |
| Heron Therapeutics, INC. | $152.11 | 2021 | |
| Orthalign INC | $150.00 | 2024 | Orthalign Plus |
| Baudax Bio INC. | $83.04 | 2021 | |
| Medtronic, INC. | $50.15 | 2022 | |
| Biocomposites INC | $46.08 | 2023 | Stimulan |
| Bioventus LLC | $45.56 | 2024 | Exogen Ultrasound Bone Healing System, Durolane |
| Alafair Biosciences, INC. | $37.44 | 2023 | Versawrap |
| Pacira Pharmaceuticals Incorporated | $17.86 | 2025 | Iovera |
| Sanofi-Aventis U.S. LLC | $16.96 | 2020 | |
| Ferring Pharmaceuticals INC. | $16.80 | 2024 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $14.13 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $3.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cambize Shahrdar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.